- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Cost-Effectiveness of Blood Glucose Monitoring Is Controversial
TO THE EDITORS
:
VA Center for Medication Safety, Hines VA
Center for Health Equity Research and Promotion, VA
School of Pharmacy
VA Greater Los Angeles Healthcare System
Los Angeles, California
Funding: None reported.
Author Disclosure: The authors report no relationship or financial interest with any entity that would pose a conflict of interest with the subject matter of this article.
Address correspondence to: Sherrie L. Aspinall, PharmD, MSc, VA Pittsburgh Healthcare System, Center for Health Equity Research and Promotion (151C-H), 7180 Highland Dr, Pittsburgh, PA 15206. E-mail: sherrie.aspinall@med.va.gov.
References
2. Karter AJ, Parker MM, Moffet HH, et al. Longitudinal study of new and prevalent use of self-monitoring of blood glucose. Diabetes Care. 2006;29(8):1757-1763.
4. Davidson MB, Castellanos M, Kain D, Duran P. The effect of self monitoring of blood glucose concentrations on glycated hemoglobin levels in diabetic patients not taking insulin: a blinded, randomized trial. Am J Med. 2005;118(4):422-425.
IN REPLY
:
Health Economics and Outcomes Research
Noblesville, IN
Funding: LifeScan, A Johnson and Johnson Company.
Author Disclosures: The authors (SLT, MEM) are employees of IMS, a company that provides contracted research consulting to LifeScan.
Address correspondence to: Sandra L. Tunis, PhD, Health Economics and Outcomes Research, IMS Consulting Services, 14701 Cumberland Rd, Ste 107, Nobelsville, IN 46060. E-mail: stunis@us.imshealth.com.
1.Tunis SL, Minshall ME. Self-monitoring of blood glucose in type 2 diabetes: cost-effectiveness in the United States. Am J Manag Care. 2008;14(3):131-140.
3. Centers for Disease Control and Prevention, National Center for Health Statistics. National Nutrition and Health Examination Survey (NHANES) data. Hyattsville, MD: US Department of Health and Human Services; 2000.
Insurance Payer Is Associated With Length of Stay After Traumatic Brain Injury
February 21st 2025Among hospitalized patients with traumatic brain injury, Medicaid fee-for-service was associated with longer hospital stays than private insurance and Medicaid managed care organizations.
Read More
Managed Care Reflections: Insights From Richard J. Gilfillan, MD; and Donald M. Berwick, MD, MPP
February 20th 2025To mark the 30th anniversary of The American Journal of Managed Care (AJMC), each issue in 2025 includes reflections from a thought leader on what has changed over the past 3 decades and what’s next for managed care. The February issue features a retrospective by Richard J. Gilfillan, MD, former director of the Center for Medicare and Medicaid Innovation; and Donald M. Berwick, MD, MPP, former administrator of CMS.
Read More
Medical Policy Determinations for Pharmacogenetic Tests Among US Health Plans
February 10th 2025This analysis demonstrated significant variability in medical policy determinations and evidence cited for clinically relevant pharmacogenetic tests among major US health insurers and laboratory benefit managers.
Read More
